Vertex Pharmaceuticals recently presented updated interim data at the 2025 ASN Kidney Week, revealing significant proteinuria ...
Detailed price information for Navitas Semiconductor Corp (NVTS-Q) from The Globe and Mail including charting and trades.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2025, and refined full year 2025 financial guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback